CIK 0001870144 · <br>Emerging growth company
Cardio Diagnostics Holdings, Inc.
Sign in to watch- Ticker
- CDIO
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870925574
- Phone
- 855-226-9991
- Business address
- 311 W. SUPERIOR STREET, SUITE 444, CHICAGO, IL, 60645
- Former names
- Mana Capital Acquisition Corp.
Securities
- CDIO Common stock Nasdaq
- CDIOW Warrant Nasdaq
- 8-K Event Delisting notice
- 8-K/A Event Material agreement · New debt or obligation · Unregistered share sale
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Chief Executive Officer bought 18,251 shares at an average $0.55 ($9,964)
- 4 Open-market buy Chief Technology Officer bought 18,251 shares at an average $0.55 ($9,964)
- 4 Open-market buy Chief Medical Officer bought 34,000 shares at an average $0.60 ($20,395)
- 10-Q Report Quarterly Report
- 4 Option exercise Director acquired 29,411 shares (option exercise)
- 4 Option exercise Director acquired 21,008 shares (option exercise)
- 4 Option exercise Director acquired 21,008 shares (option exercise)
- 4 Option exercise Director acquired 21,008 shares (option exercise)
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 15 · 296 filings